Factors associated with early reperfusion improvement after intra-arterial fibrinolytics as rescue for mechanical thrombectomy

Objective: To identify factors associated with early angiographic reperfusion improvement (EARI) following intra-arterial fibrinolytics (IAF) after failed or incomplete mechanical thrombectomy (MT). Methods: A subset of patients treated with MT and IAF rescue after incomplete reperfusion included in the INFINITY (INtra-arterial FIbriNolytics In ThrombectomY) multicenter observational registry was analyzed. Multivariable logistic regression was used to identify factors associated with EARI. Heterogeneity of the clinical effect of EARI on functional independence (defined as modified Rankin Score ≤2) was tested with interaction terms. Results: A total of 228 patients (median age: 72 years, 44.1% female) received IAF as rescue for failed or incomplete MT and had a post-fibrinolytic angiographic control run available (50.9% EARI). A cardioembolic stroke origin (adjusted odds ratio (aOR) 3.72, 95% confidence interval (CI) 1.39–10.0) and shorter groin puncture to IAF intervals (aOR 0.82, 95% CI 0.71–0.95 per 15-min delay) were associated with EARI, while pre-interventional thrombolysis showed no association (aOR 1.15, 95% CI 0.59–2.26). The clinical benefit of EARI after IAF seemed more pronounced in patients without or only minor early ischemic changes (Alberta Stroke Program Early Computed Tomography Score (ASPECTS) ≥9, aOR 4.00, 95% CI 1.37–11.61) and was absent in patients with moderate to severe ischemic changes (ASPECTS ≤8, aOR 0.94, 95% CI 0.27–3.27, p for interaction: 0.095). Conclusion: Early rescue and a cardioembolic stroke origin were associated with more frequent EARI after IAF. The clinical effect of EARI seemed reduced in patients with already established infarcts. If confirmed, these findings can help to inform patient selection and inclusion criteria for randomized-controlled trials evaluating IAF as rescue after MT.

[1]  M. Goyal,et al.  A review of endovascular treatment for medium vessel occlusion stroke , 2021, Journal of NeuroInterventional Surgery.

[2]  P. Mordasini,et al.  Safety and efficacy of intra-arterial fibrinolytics as adjunct to mechanical thrombectomy: a systematic review and meta-analysis of observational data , 2021, Journal of NeuroInterventional Surgery.

[3]  D. Kallmes,et al.  Systematic review and meta-analysis of current rates of first pass effect by thrombectomy technique and associations with clinical outcomes , 2021, Journal of NeuroInterventional Surgery.

[4]  J. Pekkola,et al.  Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry , 2021, Journal of stroke.

[5]  B. Campbell,et al.  Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop? , 2020, Stroke.

[6]  P. Mordasini,et al.  Effect of Pre- and In-Hospital Delay on Reperfusion in Acute Ischemic Stroke Mechanical Thrombectomy , 2020, Stroke.

[7]  D. Liebeskind,et al.  Thrombectomy for Distal, Medium Vessel Occlusions , 2020, Stroke.

[8]  Futile complete recanalization: patients characteristics and its time course , 2020, Scientific Reports.

[9]  K. Fargen,et al.  Abstract TP12: The Trend of Successful First Pass in M2 Segment Stroke Thrombectomy- Insights From the STAR Collaboration , 2020, Stroke.

[10]  K. Fargen,et al.  Abstract 168: Outcomes of Intra-Arterial Tissue Plasminogen Activator Rescue Therapy During Stroke Thrombectomy-Insights From the STAR Collaboration , 2020, Stroke.

[11]  Dong Joon Kim,et al.  Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke , 2020, Journal of stroke.

[12]  A. Alexandrov,et al.  Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke , 2020, Journal of stroke.

[13]  Á. Chamorro,et al.  The Chemical Optimization of Cerebral Embolectomy trial: Study protocol , 2019, International journal of stroke : official journal of the International Stroke Society.

[14]  G. Schroth,et al.  Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke. , 2019, JAMA neurology.

[15]  S. Desai,et al.  Successful reperfusion, rather than number of passes, predicts clinical outcome after mechanical thrombectomy , 2019, Journal of NeuroInterventional Surgery.

[16]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[17]  M. Jumaa,et al.  Response by Castonguay et al to Letter Regarding Article "Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions". , 2019, Stroke.

[18]  Ivo G. H. Jansen,et al.  Thrombus Migration Paradox in Patients With Acute Ischemic Stroke , 2019, Stroke.

[19]  D. Gandhi,et al.  Beyond the first pass: revascularization remains critical in stroke thrombectomy , 2019, Journal of NeuroInterventional Surgery.

[20]  A. Spiotta,et al.  Intra-Arterial Tissue Plasminogen Activator Is a Safe Rescue Therapy with Mechanical Thrombectomy. , 2019, World neurosurgery.

[21]  M. Mazighi,et al.  European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke , 2019, Journal of NeuroInterventional Surgery.

[22]  Götz Thomalla,et al.  Reasons for failed endovascular recanalization attempts in stroke patients , 2018, Journal of NeuroInterventional Surgery.

[23]  Michael D Hill,et al.  eTICI reperfusion: defining success in endovascular stroke therapy , 2018, Journal of NeuroInterventional Surgery.

[24]  P. Mordasini,et al.  Reasons for Reperfusion Failures in Stent-Retriever-Based Thrombectomy: Registry Analysis and Proposal of a Classification System , 2018, American Journal of Neuroradiology.

[25]  P. Mordasini,et al.  Rates and Quality of Preinterventional Reperfusion in Patients With Direct Access to Endovascular Treatment , 2018, Stroke.

[26]  D. Kallmes,et al.  Redefining ‘success’: a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization , 2018, Journal of NeuroInterventional Surgery.

[27]  Ting-yu Yi,et al.  Adjuvant intra-arterial rt-PA injection at the initially deployed solitaire stent enhances the efficacy of mechanical thrombectomy in acute ischemic stroke , 2018, Journal of the Neurological Sciences.

[28]  P. Mordasini,et al.  Systematic review and meta-analysis on outcome differences among patients with TICI2b versus TICI3 reperfusions: success revisited , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  C. Zimmer,et al.  Impact of histological thrombus composition on preinterventional thrombus migration in patients with acute occlusions of the middle cerebral artery , 2018, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[30]  W. Ashley,et al.  Intra-Arterial Alteplase Thrombolysis during Mechanical Thrombectomy for Acute Ischemic Stroke. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[31]  W. Heindel,et al.  Ischemic Stroke: Histological Thrombus Composition and Pre-Interventional CT Attenuation Are Associated with Intervention Time and Rate of Secondary Embolism , 2017, Cerebrovascular Diseases.

[32]  C. Nolte,et al.  Thrombolysis management in thrombectomy patients: Real-life data from German stroke centres , 2017, European stroke journal.

[33]  Holger Poppert,et al.  Thrombus Migration in the Middle Cerebral Artery: Incidence, Imaging Signs, and Impact on Success of Endovascular Thrombectomy , 2017, Journal of the American Heart Association.

[34]  C. Molina,et al.  Impact of Time to Treatment on Tissue-Type Plasminogen Activator–Induced Recanalization in Acute Ischemic Stroke , 2014, Stroke.

[35]  P. Akins,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[36]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.